Bladder Outlet Obstruction
29
3
5
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 29 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (29)
Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia
A Prospective Comparative Study Evaluating the Safety and Efficacy of Transurethral Thulium Fiber Laser, Holmium Laser and Bipolar Enucleation of Large Sized Prostate
Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms
Concomitant Renal and Urinary Bladder Allograft Transplantation
High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction
Predictors of Trifecta Achievement After HoLEP
Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction
Urinary CTGF in Benign Prostatic Obstruction
Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH
En-bloc With Early Apical Release Versus Lobe-by-lobe LASER Enucleation of the Prostate
A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
Day-case Endourology; Enablers, Barriers, Unexpected Outcomes
Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer
The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects
DU and BOO in Women With and Without Symptoms of VD
Prostatic Artery Embolization in Advanced Prostate Cancer
Low Energy HoLEP on IPSS
Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity